The medicine name comes first
Tirzepatide is the ingredient behind the brand names Mounjaro and Zepbound.
The US Food and Drug Administration is known as FDA. It reviews medicines against approval standards for particular uses.
As checked in September 2026, FDA had approved both brands, each for its own uses.
That makes the exact product name a useful place to pause. Ask what is being offered and what health concern it is meant to address. A broad promise about weight does not answer either question.
Care is more than the parcel
Think through the visit, the way to ask questions later and the cost of keeping care going. Write down what matters to you before reading a treatment offer. An answer can use everyday words and still be precise.
A telehealth visit is a visit held at a distance, such as by video or an online exchange.
An in-person visit happens in the same room. Either way, ask who will talk with you and how to reach them after the visit.
A useful stopping point
Before choosing care, aim to have the medicine name, the clinician’s name, a written cost and a way to ask more questions. An unclear answer can stay an open question. It does not have to become a decision today.
Open this chapter’s source notes
This chapter’s reading notes
Read the Zepbound label
The Zepbound label is its official medicine information. It gives the product details and approved uses checked for September 2026.
Read the Mounjaro label
Mounjaro’s official medicine information gives its approved uses as checked in September 2026.